56 research outputs found
The Efficacy of Emamectin Benzoate against Infestations of Lepeophtheirus salmonis on Farmed Atlantic Salmon (Salmo salar L) in Scotland, 2002–2006
Infestations of the parasitic copepod Lepeophtheirus salmonis, commonly referred to as sea lice, represent a major challenge to commercial salmon aquaculture. Dependence on a limited number of theraputants to control such infestations has led to concerns of reduced sensitivity in some sea lice populations. This study investigates trends in the efficacy of the in-feed treatment emamectin benzoate in Scotland, the active ingredient most widely used across all salmon producing regions. Study data were drawn from over 50 commercial Atlantic salmon farms on the west coast of Scotland between 2002 and 2006. An epi-informatics approach was adopted whereby available farm records, descriptive epidemiological summaries and statistical linear modelling methods were used to identify factors that significantly affect sea lice abundance following treatment with emamectin benzoate (SLICEH, Schering Plough Animal Health). The results show that although sea lice infestations are reduced following the application of emamectin benzoate, not all treatments are effective. Specifically there is evidence of variation across geographical regions and a reduction in efficacy over time. Reduced sensitivity and potential resistance to currently available medicines are constant threats to maintaining control of sea lice populations on Atlantic salmon farms. There is a need for on-going monitoring of emamectin benzoate treatment efficacy together with reasons for any apparent reduction in performance. In addition, strategic rotation of medicines should be encouraged and empirical evidence for the benefit of such strategies more fully evaluated
Investigative Interviews with Victims of Child Sexual Abuse: The Relationship between Question Type and Investigation Relevant Information
Predictors of pulmonary failure following severe trauma: a trauma registry-based analysis
Background: The incidence of pulmonary failure in trauma patients is considered to be influenced by several factors such as liver injury. We intended to assess the association of various potential predictors of pulmonary failure following thoracic trauma and liver injury.
Methods: Records of 12,585 trauma patients documented in the TraumaRegister DGU® of the German Trauma Society were analyzed regarding the potential impact of concomitant liver injury on the incidence of pulmonary failure using uni- and multivariate analyses. Pulmonary failure was defined as pulmonary failure of ≥ 3 SOFA-score points for at least two days. Patients were subdivided according to their injury pattern into four groups: group 1: AIS thorax < 3; AIS liver < 3; group 2: AIS thorax ≥ 3; AIS liver < 3; group 3: AIS thorax < 3; AIS liver ≥ 3 and group 4: AIS thorax ≥ 3; AIS liver ≥ 3.
Results: Overall, 2643 (21%) developed pulmonary failure, 12% (n= 642) in group 1, 26% (n= 697) in group 2, 16% (n= 30) in group 3, and 36% (n= 188) in group 4. Factors independently associated with pulmonary failure included relevant lung injury, pre-existing medical conditions (PMC), sex, transfusion of more than 10 units of packed red blood cells (PRBC), Glasgow Coma Scale (GCS) ≤ 8, and the ISS. However, liver injury was not associated with an increased risk of pulmonary failure following severe trauma in our setting.
Conclusions: Specific factors, but not liver injury, were associated with an increased risk of pulmonary failure following trauma. Trauma surgeons should be aware of these factors for optimized intensive care treatment
Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin
Streptococcus pneumoniae and Listeria monocytogenes, pathogens which can cause severe infectious disease in human, were used to infect properdin-deficient and wildtype mice. The aim was to deduce a role for properdin, positive regulator of the alternative pathway of complement activation, by comparing and contrasting the immune response of the two genotypes in vivo. We show that properdin-deficient and wildtype mice mounted antipneumococcal serotype-specific IgM antibodies, which were protective. Properdin-deficient mice, however, had increased survival in the model of streptococcal pneumonia and sepsis. Low activity of the classical pathway of complement and modulation of FcγR2b expression appear to be pathogenically involved. In listeriosis, however, properdin-deficient mice had reduced survival and a dendritic cell population that was impaired in maturation and activity. In vitro analyses of splenocytes and bone marrow-derived myeloid cells support the view that the opposing outcomes of properdin-deficient and wildtype mice in these two infection models is likely to be due to a skewing of macrophage activity to an M2 phenotype in the properdin-deficient mice. The phenotypes observed thus appear to reflect the extent to which M2- or M1-polarised macrophages are involved in the immune responses to S. pneumoniae and L. monocytogenes. We conclude that properdin controls the strength of immune responses by affecting humoral as well as cellular phenotypes during acute bacterial infection and ensuing inflammation
The validity of a portable clinical force plate in assessment of static postural control: concurrent validity study
Background
The broad use of force plates in clinical settings for postural control assessment suggests the need for instruments that are easy to use, affordable and readily available. In addition, these instruments of measurement should be reliable and valid as adequate reliability and validity are prerequisites to making correct inferences. The aim of this study was to examine the concurrent validity of postural control measures obtained with a clinical force plate.
Methods
Thirty-one healthy adults were recruited. Participants completed 1 set of 5 trials on each force plate. Postural control measures (centre of pressure [COP] average velocity and sway area) were collected and compared using the Midot Posture Scale Analyzer (clinical force plate) and the Accugait force plate (criterion measure). Intra class correlation coefficient (ICC), standard error of measurement , and paired t-tests were calculated and Bland-Altman plots were constructed to compare the force plates and assess consistency of measurement and agreement between them.
Results
The ICC values (ICC = 0.14-0.60) between the two force plates were lower than the acceptable value for both COP average velocity and sway area. There was significant difference (p > 0.05) in COP average velocity and sway area between the force plates. Examination of the plots revealed that there is less difference between the force plates in lower magnitudes of COP for average velocity and sway area however, the greater the average velocity and sway area, the greater the difference between the measures obtained from the two force plates.
Conclusion
Findings of this study showed poor concurrent validity of the clinical force plate. This clinical force plate cannot be a replacement for known reliable and valid force plates and consequently measures obtained from this force plate should be treated with caution especially in a clinical population
Nutrition Programs Enhance Exercise Effects on Body Composition and Resting Blood Pressure
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
Objective: Metformin is a first-line pharmacotherapy in the treatment of type 2 diabetes, a condition closely associated with NAFLD. Although metformin promotes weight loss and improves insulin sensitivity, its effect on intrahepatic triglyceride (IHTG) remains unclear.
We investigated the effect of metformin on IHTG, hepatic de novo lipogenesis (DNL) and
fatty acid (FA) oxidation in vivo in humans.
Design and Methods: Metabolic investigations, using stable-isotope tracers, were performed in 10 insulin-resistant, overweight/obese human participants with NAFLD who were treatment naïve before and after 12-weeks of metformin treatment. The effect of metformin on markers of subcutaneous adipose tissue FA metabolism and function, along with the plasma metabolome were investigated.
Results: Twelve weeks treatment with metformin resulted in a significant reduction in body weight and improved insulin sensitivity, but IHTG content and FA oxidation remained unchanged. Metformin treatment was associated with a significant decrease in VLDLtriglyceride (TG) concentrations and a significant increase in the relative contribution of
DNL-derived FAs to VLDL-TG. There were subtle and relatively few changes in subcutaneous adipose tissue FA metabolism and the plasma metabolome with metformin treatment.
Conclusions: We demonstrate the mechanisms of action of metformin whereby it improves insulin sensitivity and promotes weight loss, without improvement in IHTG; these observations are partly, explained through increased hepatic DNL and a lack of change in
fatty acid oxidation.</p
Spina bifida and lower limb amputation in Northern Ireland: A retrospective study of demographics and outcome
- …